HRC Wealth Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-300
Closed -$234K 56
2025
Q2
$234K Hold
300
0.12% 47
2025
Q1
$248K Hold
300
0.15% 44
2024
Q4
$232K Hold
300
0.14% 46
2024
Q3
$266K Hold
300
0.17% 37
2024
Q2
$272K Hold
300
0.19% 36
2024
Q1
$233K Buy
+300
New +$214K 0.17% 35

Other funds holding LLY

HRC Wealth Management's LLY Position: Q3 2025 in Review

HRC Wealth Management sold out of Eli Lilly (LLY) in Q3 2025, closing a stake of 300 shares — an estimated $234K sold.

HRC Wealth Management first reported a position in LLY in Q1 2024 and held it in 6 quarters. The position peaked at $272K in Q2 2024. 3,897 funds tracked by Wall St. Rank hold LLY as of Q3 2025.

  • HRC Wealth Management reported no remaining Eli Lilly position as of Q3 2025 after selling out during the quarter.
  • HRC Wealth Management sold 300 Eli Lilly shares in Q3 2025, an estimated $234K.
  • HRC Wealth Management first reported a position in Eli Lilly in Q1 2024 and held it in 6 quarters.
  • HRC Wealth Management's Eli Lilly position peaked at $272K in Q2 2024.
  • 3,897 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2025.

Based on HRC Wealth Management's 13F filing for Q3 2025, filed 15 Oct 2025.